Axa S.A. Heron Therapeutics, Inc. Transaction History

Axa S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.51 - $3.25 $19,177 - $41,275	-12,700 Reduced 4.57%	265,000 $400,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $738,682 - $1.49 Million	277,700 New	277,700 $1.17 Million
Q4 2018 Feb 13, 2019	SELL	$22.03 - $32.01 $614,637 - $893,079	-27,900 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$30.0 - $40.85 $93,000 - $126,635	3,100 Added 12.5%	27,900 $883,000
Q2 2018 Aug 13, 2018	BUY	$26.4 - $42.0 $654,720 - $1.04 Million	24,800 New	24,800 $963,000

175

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $202M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.